Salesforce.com, Inc. (CRM) Tops Q2 EPS by 1c; Issues Inline Q3 EPS Outlook

salesforce.com (CRM) Q2 Beat on Key Metrics - Nomura Securities

Nomura Securities analyst Rick Sherlund reiterated a Buy rating and $65 price target on salesforce.com (NYSE: CRM) following Q2 results which beat on key metrics.

Sherlund commented, "Revenue growth of 38% (we estimate 28% organic) was ahead of expectations of 35%. Billings growth of 33% (we estimate 28%... More

salesforce.com (CRM) Bullish Stance Reiterated BofA/Merrill Lynch on Strong Fundamentals

BofA/Merrill Lynch analyst Kash Rangan reiterated a Buy rating and $73 price target on salesforce.com (NYSE: CRM) following Q2 results noting several key metrics came in above the magic number of 30; revenue grew 38%, reported billings grew 33%, off BS backlog grew 32%, cash flow grew... More

salesforce.com (CRM) Q2 'Solid' Across the Board, Needham & Company Says

Needham & Company analyst Michael Huang reiterated a Buy rating and $70 price target on salesforce.com (NYSE: CRM) following a solid across-the-board quarter.

Huang commented, "Q2 was solid across the board, which suggests the health of fundamentals and secular trends. Were encouraged... More

Salesforce (CRM) CL-Buy Rating Reiterated at Goldman Sachs

Goldman Sachs maintained a Conviction Buy rating on salesforce.com (NYSE: CRM) with a price target of $74. Comments follow Q2 results. Analyst Heather Bellini noted potential for acceleration in organic growth.

"As expected, key metrics showed slight upside versus expectations. Revenue of $1.32bn (+38% yoy, 7.5% qoq) beat consensus estimates by $29mn,... More

salesforce.com (CRM) Price Target Raised to $70 at Deutsche Bank

Deutsche Bank reiterated a Buy rating on salesforce.com (NYSE: CRM) and raised its price target to $70.00 (from $65.00). The change follows Q2 results and guidance. Analyst Karl Keirstead thinks set-up heading into the second half has improved.

"Salesforce.com (SFDC) grew billings by 33% in 2QF15 (we estimate organic ex- ET billings... More